Attention Chemists: All Pharmacies to Mandatorily Display PvPI QR Code, ADR Toll-Free Number Susmita Roy22 Nov 2025 3:22 PM ISTNew Delhi: Every chemist and pharmacist in the country will now be required to mandatorily display the Pharmacovigilance Programme of India (PvPI) QR...
No Trial Waiver: CDSCO Panel Directs Sun Pharma to Run Phase III Study for Somatropin Liquid Injection Citing Lack of India-Specific Data Susmita Roy21 Nov 2025 4:26 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has opined that the drug major Sun...
Entod Pharma gets CDSCO Panel nod to conduct Phase IV CT of Atropine Sulfate Ophthalmic Solution USP 0.05% Susmita Roy19 Nov 2025 10:42 PM ISTNew Delhi: Approving the proposal for a Phase IV clinical study for Atropine Sulfate Ophthalmic Solution USP 0.05% w/v, the Subject Expert Committee...
High-Level Ethiopia Delegation Meets DCGI, IPC to Strengthen Pharmaceutical Ties Susmita Roy18 Nov 2025 6:33 PM ISTNew Delhi: In a significant step toward reshaping pharmaceutical cooperation across the Global South, India and Ethiopia have taken concrete strides...
CDSCO Panel Asks Pure and Cure Healthcare To Revise Phase III Protocol of Tapinarof Cream 1% for Adult Psoriasis Susmita Roy17 Nov 2025 7:01 PM ISTNew Delhi: In response to the proposal submitted by Pure and Cure Healthcare, the Subject Expert Committee (SEC) on Dermatology and Allergy,...
Danish Lab Chief Held for Allegedly Supplying Fake Amoxycillin, Cefixime Under SVR Healthcare's Name Parthika Patel17 Nov 2025 6:53 PM ISTAmbala: In a significant enforcement action exposing a dangerous counterfeit drug operation, the Paonta Sahib police have arrested Aniketh Jain, owner...
Dr Reddy's Told to Justify Patient Numbers in Vonoprazan Phase IV Trial, Revise Protocol Parthika Patel16 Nov 2025 11:15 AM ISTNew Delhi: Noting that the sample size was "too small" for a Phase IV study of Vonoprazan Tablets 10 mg and 20 mg, the Subject Expert Committee (SEC)...
CDSCO Panel Asks Abbott for Proof-of-Concept Study on UDCA for Dengue Hepatic Dysfunction Parthika Patel14 Nov 2025 2:00 PM ISTNew Delhi: Raising key scientific and clinical concerns, the Subject Experts Committee (SEC) has declined to recommend the Phase III clinical trial...
CDSCO Panel Asks Zydus Lifesciences to Revise Phase I Protocol for Inactivated Chikungunya Vaccine Susmita Roy13 Nov 2025 9:01 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Vaccines, under the Central Drugs Standard Control Organisation (CDSCO), has directed Zydus...
Health Ministry Notifies New CDSCO Drugs Inspector Recruitment Rules, 419 Posts Sanctioned for 2025 Susmita Roy13 Nov 2025 3:45 PM ISTNew Delhi: In a major move to strengthen the country's drug regulatory framework, the Ministry of Health and Family Welfare has notified new...
DCGI Orders Nationwide GMP Inspection Drive to Enforce Revised Schedule M Susmita Roy12 Nov 2025 10:43 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) has directed all states and Union Territories to immediately launch a nationwide inspection...
Sanofi's Tetraxim Vaccine Gets CDSCO Panel Nod for Expanded Indication Susmita Roy11 Nov 2025 10:02 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organization (CDSCO), has approved an additional...
